The key ingredient to effective cancer treatments
About 50 percent of cancer patients have tumors that are resistant to radiation because of low levels of oxygen—a state known as hypoxia. A startup in San Francisco is developing proteins that could carry oxygen to tumors more effectively, increasing the odds that radiation therapy will help these patients.
Last month, the National Cancer Institute (NCI) gave that startup, Omniox, $3 million in funding. Omniox is collaborating with researchers at the NCI to test whether its oxygen-carrying compounds improve radiation therapy in animals with cancer.
- 3 Favorite Nursing Trends of 2013
- Hospital Compare Adds Infection, Stroke, Readmissions Data
- Premier: ACOs Poised for Growth
- SGR Bill's Payment Transparency Provision Elicits Concern
- Intelligence Report: Cost-Containment Expertise
- ICD-10: Minimizing the Financial Hit
- Your Meetings are Wasting Big Money
- AAFP: 72% of Patients Prefer Physicians to NPs
- 7 Signs Providers Are Opening Up About Bad Healthcare Outcomes
- SGR Repeal Bill Holds Extra Promise for Rural Hospitals